Depressive disorders: systematic review of approved psychiatric medications (2009-April 2025) and pipeline phase 3 medications. [PDF]
IsHak WW +15 more
europepmc +1 more source
Kappa Counterconditioning of Cocaine Cues [PDF]
Mantsch, John R., Twining, Robert C.
core +1 more source
Neuroimaging epicenters and the related neurobiological signatures in patients with postherpetic neuralgia. [PDF]
Li Q +20 more
europepmc +1 more source
Neuronal Colocalization of μ-Opioid Receptor, κ-Opioid Receptor, and Oxytocin Receptor mRNA in the Central Nucleus of the Amygdala in Male and Female Mice. [PDF]
Nisbett KE, Koob GF.
europepmc +1 more source
Genetic and Epigenetic Approaches to Opioid Use Disorder. [PDF]
Ranadeva ND +6 more
europepmc +1 more source
Strategy for effective analgesia with intravenous buprenorphine in patients with acute postoperative pain. [PDF]
Szczupak M +5 more
europepmc +1 more source
Pruritus in Uremic Patients: Approaches to Alleviating a Common Symptom in Chronic Kidney Disease. [PDF]
Cîrstea Ș, Orzan OA, Zilișteanu DS.
europepmc +1 more source
Phenolic Compounds of <i>Justicia gendarussa</i> Show Pharmacological Potentials Against Pain, Oxidation, Hyperglycemia, Diarrhea, and Microbes: Phytopharmacological and Computational Approaches. [PDF]
Munny FA +10 more
europepmc +1 more source
Pharmacogenomics of buprenorphine - a narrative review. [PDF]
Aravindan L +9 more
europepmc +1 more source
Nalfurafine is Aversive at Antinociceptive Doses in Mice. [PDF]
Kuijer EJ +6 more
europepmc +1 more source

